Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferulic acid + Angelica archangelica in mild Alzheimer's dementia
jRCTs031220615Recruiting
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Alzheimer's disease (AD) comparing Ferulic acid + Angelica archangelica extract arm with Placebo arm (2 arms). Primary endpoint: Percent change from baseline in ADAS-Cog-13 (Japanese version). Started Feb 2023; status: recruiting.
02
Drugs
ferulic acid + angelica archangelica extract
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCTs031220615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220615.